- Prostate-Specific Antigen (PSA) Test - NCI - National Cancer Institute
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise The PSA test measures the level of PSA in the blood This test is used in several different ways: to monitor the
- Prueba del antígeno prostático específico (PSA)
The single-parameter, structure-based IsoPSA assay demonstrates improved diagnostic accuracy for detection of any prostate cancer and high-grade prostate cancer compared to a concentration-based assay of total prostate-specific antigen: A preliminary report
- Understanding Prostate Changes - NCI - National Cancer Institute
Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer Talk with your doctor about prostate cancer screening tests (DRE, PSA)
- Prostate Cancer Screening - NCI
Prostate cancer screening may help detect prostate cancer, but remains controversial as it has not been shown to reduce deaths from prostate cancer Learn more about prostate cancer screening, including the potential benefits and harms, in this expert-reviewed summary
- Prostate Cancer Treatment - NCI
Prostate cancer treatment can include active surveillance, surgery, radiation therapy, hormonal therapy, chemotherapy, immunotherapy, and supportive care Learn more about treatment options for prostate cancer in this expert-reviewed summary
- Prostate Cancer Screening (PDQ®) - NCI
Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians
- Prostate Cancer Prevention - NCI
Prostate cancer prevention approaches include avoiding risk factors when possible, increasing protective factors, and chemoprevention Learn more about prostate cancer prevention in this expert-reviewed summary
- PSA (Prostatic Specific Antigen) Lab Value | EOD Data SEER*RSA
Description PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer This data item pertains to PSA lab value Serum PSA is the most sensitive tumor marker for monitoring individuals with prostate cancer, including progression of disease and response to therapy
|